| Literature DB >> 32322760 |
Sandleen Feroz1, Nawshad Muhammad2, Jithendra Ranayake1, George Dias1.
Abstract
Keratin constitutes the major component of the feather, hair, hooves, horns, and wool represents a group of biological material having high cysteine content (7-13%) as compared to other structural proteins. Keratin -based biomaterials have been investigated extensively over the past few decades due to their intrinsic biological properties and excellent biocompatibility. Unlike other natural polymers such as starch, collagen, chitosan, the complex three-dimensional structure of keratin requires the use of harsh chemical conditions for their dissolution and extraction. The most commonly used methods for keratin extraction are oxidation, reduction, steam explosion, microbial method, microwave irradiation and use of ionic liquids. Keratin -based materials have been used extensively for various biomedical applications such as drug delivery, wound healing, tissue engineering. This review covers the structure, properties, history of keratin research, methods of extraction and some recent advancements related to the use of keratin derived biomaterials in the form of a 3-D scaffold, films, fibers, and hydrogels.Entities:
Keywords: Biomedical applications; Keratin; Natural polymer; Wool
Year: 2020 PMID: 32322760 PMCID: PMC7171262 DOI: 10.1016/j.bioactmat.2020.04.007
Source DB: PubMed Journal: Bioact Mater ISSN: 2452-199X
Fig. 1(a) Alpha-helices are right-handed individually (b) Two individual right-handed alpha-helix polypeptide further crosslinked by disulfide bonds to form left-handed coiled-coil dimers. (c) side-by-side or end-to-end aggregation of dimers by sulfide crosslinking forms protofilaments (d) two protofilaments when laterally associated forms protofibrils. (e) Intermediate filaments (7 mm diameter) consist of four protofibrils associated with a helical or circular manner. These intermediate filaments are surrounded by amorphous keratin matrix and constitute the basic structural units of keratin [34].
Fig. 2Diagrammatic illustration of keratin structure. Various inter and intramolecular bonding (hydrogen, ionic, disulfide bonds) increased the stability/strength of the keratin materials [46].
Fig. 3Classification of methods for keratin extraction from different sources such as feathers, wool, and hooves.
Some of the wool keratin extraction conditions by using ionic liquid.
| MATERIAL | PROCESSING CONDITIONS | % YIELD OF KERATIN | REF | ||||
|---|---|---|---|---|---|---|---|
| Temperature (°C) | Time | Solubility | Solid: liquid ratio | ||||
| [Bmim]Br | Wool | 130 | 10 h | 2% | – | – | [ |
| [Bmim]Cl | Wool | 100 | 10 h | 4% | – | – | [ |
| [Bmim]Cl | Wool | 130 | 10 h | 11% | – | – | [ |
| [Amim]Cl | Wool | 130 | 10 h | 8% | – | – | [ |
| [Bmim]BF4 | Wool | 130 | 24 h | insoluble | – | – | [ |
| [Bmim]PF6 | Wool | 130 | 24 h | insoluble | – | – | [ |
| [Amim]Cl | Wool | 130 | 640min | 21% | – | – | [ |
| [Bmim]Cl | Wool | 130 | 535min | 15% | – | – | [ |
| [Bmim]Cl | Wool | 120 | 30min | – | 1:6 | 57% | [ |
| [Bmim]Cl | Wool | 150 | 30min | – | 1:6 | 35% | [ |
| [Bmim]Cl | Wool | 180 | 30min | – | 1:6 | 18% | [ |
| [Amim][dca] | Wool | 130 | – | 23% | – | – | [ |
| [Bmim]Cl | Wool | 130 | – | 12% | – | – | [ |
| [Amim]Cl | Wool | 130 | – | 10% | – | – | [ |
| Choline thioglycolate | Wool | 130 | – | 11% | – | – | [ |
Keratin based biomaterials for various biomedical applications.
| COMPOSITION | PROCESSING CONDITIONS | APPLICATIONS | REF | ||
|---|---|---|---|---|---|
| Keratin dialysate (aq) with alkaline keratin dialysate | Glycerol (1%) was used as a softening agent. Curing of aqueous/alkaline keratin dialysate for 2 h at 100 °C. | Wound healing of corneal epithelial was observed | [ | ||
| Photo active keratin derived films | Films were doped with varying concentrations of methylene blue | Photodynamic therapy treatment, wound healing, tissue engineering | [ | ||
| Keratin film crosslinked by transglutaminase (TG) | 18 h treatment with TGase (30 U/g keratin) at 40 °C | Drug delivery, improve stability in artificial gastric juice environment | [ | ||
| Photo cross-linkable keratin-polyethylene glycol (PEG) hydrogels via the thiol-norborene “click” reaction | Thiol–norborene click reaction to fabricate keratin-polyethylene glycol (PEG) hydrogels. | 2-D & 3-D cell culture substrates, microfabrication techniques such as photopatterning, wet spinning. | [ | ||
| Keratin film | Mixing ratios of keratin dialysate and alkaline keratin dialysate were 100, 90/10, 80/20, 70/30 and 50/50. | Reconstruction of ocular surface | [ | ||
| Keratin film | Glycerol and shindai keratin dried for about 24 h in a 50 °C ventilated oven. | These films continuously released loaded Rhodamine B for 12 h. | [ | ||
| Keratin, chitosan/gelatine 1:1:2 (w/w) | Gelatine concentration in solution was 5 mg/ml. | soft tissue engineering | [ | ||
| Keratin -chitosan | CH solutions 2% (w/v), ethylene glycol (1.5 ml). | Wound dressing material | [ | ||
| PLA/chitosan/keratin composites | A 111: PLA (70%), chitosan (30%). | Facilitates attachment and proliferation of osteoblast | [ | ||
| Keratin/poly (vinyl alcohol) composite | 10% keratin poly (vinyl alcohol) cross linked with 10% glyoxal | Nano fibres with high optical transmittance | [ | ||
| Keratin wound dressing | Porcine lethal extremity hemorrhage model | As hemostatic material | [ | ||
| Keratin gel | Feather-keratin derived hydrogel | The drug release rate was 97% at pH 8.4 for 24 h. | [ | ||
| Keratin gel | Human hair keratin alkylation | Act as a substrate for cellular attachment and proliferation, delivery of therapeutic agents | [ | ||
| Hydrogels in injectable forms | For repairing cardiac tissue after myocardial infarction. | [ | |||
| Keratin hydrogel | Glycerol (3%) to formulate 20% (w/v) solution. | Pupal tissue regeneration | [ | ||
| Keratin hydrogel | Fibroblasts culturing | [ | |||
| Recombinant keratin proteins | Two recombinant trichocyte keratins expressed by using a bacterial expression system. | Dermal wound healing | [ | ||
| Keratin hydrogel | Konjac glucomannan (KGM), human hair proteins (KER), ethanolic extract of Avena sativa (OAT) | Dressing material for diabetic wounds. | [ | ||
| Keratin based therapeutic dermal patches | Mixing keratin and exopolysaccharide solutions in defined concentrations. | Wound healing | [ | ||
| Keratin/poly (vinyl alcohol) nanofibers | Keratose/PVA mass ratios (1:1, 1:3, 1:5 and 1:7). | Tissue engineering. | [ | ||
| Keratin derived eco-friendly bioplastic film | Bioplastic film fabrication using glycerol (3.5%), microcrystalline cellulose (0.2%) in NaOH at 60 °C for 48 h. | Biopolymer, biomedical and pharmaceutical industries. | [ | ||
Fig. 4A. The urethrography of Group A (experimental group) showed patent urethra. B. Group A reconstructed urethra showed minor scar in the reconstructed site. C. Intact epithelial layer observed by H & E staining in group A. D, E. confirmation of regenerated epithelial layer in group A on the repaired site by immunohistochemical examination of AE1/AE3 and - smooth actin antibody. F. Group B (negative control) urethrography showed urethral fistula. G. Gross view of fistula in a reconstructed site in Group B. H. inflammatory response observed by H&E staining in group B. I, J. Epithelial layer and smooth muscle cells cannot be viewed in group B by immunohistochemical examination of AE1/AE3 and - smooth actin antibody. K. The urethrography of group C (positive control group) showed patent urethra. L. Group C reconstructed urethra showed minor scar in reconstructed site. M. Intact epithelial layers observed by H & E staining in group C. N, O. Confirmation of regenerated epithelial layer on the repaired site by immunohistochemical examination of group C (161).
Fig. 5A: Stereo microscopic images of negative control (a & b) of non-treated mouse sites, (c & d) keratin-hydrogel treated mouse, (e) post wounding natural mouse skin at day 0 and 21. B: Histological images of eosin (H&E) and hematoxylin staining of non-treated (a–c), keratin -hydrogels treated (d–f), and natural skin (g–i) [172].